These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10636257)

  • 1. Hemodynamic comparison of twice daily metoprolol tartrate with once daily metoprolol succinate in congestive heart failure.
    Kukin ML; Mannino MM; Freudenberger RS; Kalman J; Buchholz-Varley C; Ocampo O
    J Am Coll Cardiol; 2000 Jan; 35(1):45-50. PubMed ID: 10636257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta blockade in congestive heart failure: persistent adverse haemodynamic effects during chronic treatment with subsequent doses.
    Kukin ML; Kalman J; Mannino MM; Buchholz-Varley C; Ocampo O
    Heart; 1997 Nov; 78(5):444-9. PubMed ID: 9415001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation.
    Kalman J; Buchholz C; Steinmetz M; Courtney M; Gass A; Lansman S; Kukin ML
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1212-7. PubMed ID: 8719469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined alpha-beta blockade (doxazosin plus metoprolol) compared with beta blockade alone in chronic congestive heart failure.
    Kukin ML; Kalman J; Mannino M; Freudenberger R; Buchholz C; Ocampo O
    Am J Cardiol; 1996 Mar; 77(7):486-91. PubMed ID: 8629589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term and long-term hemodynamic and clinical effects of metoprolol alone and combined with amlodipine in patients with chronic heart failure.
    Kukin ML; Freudenberger RS; Mannino MM; Kalman J; Steinmetz M; Buchholz-Varley C; Ocampo ON
    Am Heart J; 1999 Aug; 138(2 Pt 1):261-8. PubMed ID: 10426837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
    Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
    J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
    Hryniewicz K; Androne AS; Hudaihed A; Katz SD
    Circulation; 2003 Aug; 108(8):971-6. PubMed ID: 12912816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure.
    Andersson B; Blomström-Lundqvist C; Hedner T; Waagstein F
    J Am Coll Cardiol; 1991 Oct; 18(4):1059-66. PubMed ID: 1680132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.
    Waagstein F; Caidahl K; Wallentin I; Bergh CH; Hjalmarson A
    Circulation; 1989 Sep; 80(3):551-63. PubMed ID: 2548768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hemodynamic effects of moderate doses of nebivolol versus metoprolol in patients with systolic heart failure.
    Triposkiadis F; Giamouzis G; Kelepeshis G; Sitafidis G; Skoularigis J; Demopoulos V
    Int J Clin Pharmacol Ther; 2007 Feb; 45(2):71-7. PubMed ID: 17323786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure.
    Talbert RL
    Heart Fail Rev; 2004 Apr; 9(2):131-7. PubMed ID: 15516861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody against beta1-adrenergic receptor and left ventricular remodeling changes in response to metoprolol treatment.
    Miao GB; Liu JC; Liu MB; Wu JL; Zhang G; Chang J; Zhang L
    Eur J Clin Invest; 2006 Sep; 36(9):614-20. PubMed ID: 16919043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol.
    Metra M; Giubbini R; Nodari S; Boldi E; Modena MG; Dei Cas L
    Circulation; 2000 Aug; 102(5):546-51. PubMed ID: 10920067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial.
    Metra M; Torp-Pedersen C; Swedberg K; Cleland JG; Di Lenarda A; Komajda M; Remme WJ; Lutiger B; Scherhag A; Lukas MA; Charlesworth A; Poole-Wilson PA
    Eur Heart J; 2005 Nov; 26(21):2259-68. PubMed ID: 16040619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).
    Wikstrand J; Hjalmarson A; Waagstein F; Fagerberg B; Goldstein S; Kjekshus J; Wedel H;
    J Am Coll Cardiol; 2002 Aug; 40(3):491-8. PubMed ID: 12142116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment.
    Andersson B; Hamm C; Persson S; Wikström G; Sinagra G; Hjalmarson A; Waagstein F
    J Am Coll Cardiol; 1994 May; 23(6):1397-404. PubMed ID: 8176099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and clinical effects of oral levodopa in children with congestive heart failure.
    Mendelsohn AM; Johnson CE; Brown CE; Chance WT; Beekman RH
    J Am Coll Cardiol; 1997 Jul; 30(1):237-42. PubMed ID: 9207648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.
    Hjalmarson A; Goldstein S; Fagerberg B; Wedel H; Waagstein F; Kjekshus J; Wikstrand J; El Allaf D; Vítovec J; Aldershvile J; Halinen M; Dietz R; Neuhaus KL; Jánosi A; Thorgeirsson G; Dunselman PH; Gullestad L; Kuch J; Herlitz J; Rickenbacher P; Ball S; Gottlieb S; Deedwania P
    JAMA; 2000 Mar; 283(10):1295-302. PubMed ID: 10714728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.